Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Cell International
Published in: Cancer Cell International 1/2006

Open Access 01-12-2006 | Review

Cancer: looking for simplicity and finding complexity

Authors: Fabio Grizzi, Maurizio Chiriva-Internati

Published in: Cancer Cell International | Issue 1/2006

Login to get access

Abstract

Cancer is one of the most complex dynamic human disease. Despite rapid advances in the fields of molecular and cell biology, it is still widely debated as to how neoplastic cells progress through carcinogenesis and acquire their metastatic ability. The need to find a new way of observing anatomical entities and their underlying processes, and measuring the changes they undergo, prompted us to investigate the Theory of Complexity, and to apply its principles to human cancer. Viewing a neoplasm as a system that is complex in time and space it is likely to reveal more about its behavioral characteristics, and this manner of thinking may help to clarify concepts, interpret experimental data, indicate specific experiments and categorize the rich body of knowledge on the basis of the similarities and/or shared behaviors of very different tumors.
Appendix
Available only for authorised users
Literature
1.
Fould L: The natural history of cancer. J Chronic Dis. 1958, 8: 2-37. 10.1016/0021-9681(58)90039-0.CrossRef
2.
Vogelstein B, Kinzler KW: Cancer genes and the pathways they control. Nat Med. 2004, 10: 789-799. 10.1038/nm1087.CrossRefPubMed
3.
Vogelstein B, Kinzler KW: The multistep nature of cancer. Trends Genet. 1993, 9: 138-141. 10.1016/0168-9525(93)90209-Z.CrossRefPubMed
4.
Hanahan D, Weinberg RA: The hallmarks of cancer. Cell. 2000, 100: 57-70. 10.1016/S0092-8674(00)81683-9.CrossRefPubMed
5.
Bishop JM, Weinberg RA: Molecular Oncology. 1996, New York: Scientific American, Inc
6.
Bartkova J, Horejsi Z, Koed K: DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature. 2005, 434: 864-870. 10.1038/nature03482.CrossRefPubMed
7.
Hahn WC, Weinberg RA: Rules for making human tumor cells. N Engl J Med. 2002, 347: 1593-1603. 10.1056/NEJMra021902.CrossRefPubMed
8.
9.
10.
11.
Nurse P: Reductionism and explanation in cell biology. Novartis Found Symp 213. Edited by: Bock G, Goode JA. 1998, John Wiley, London, 93-105.
12.
Szathmary E, Jordan F, Pal C: Molecular biology and evolution. Can genes explain biological complexity?. Science. 2002, 292: 1315-1316. 10.1126/science.1060852.CrossRef
13.
Noble D: Modeling the heart – from genes to cells to the whole organ. Science. 2002, 295: 1678-1682. 10.1126/science.1069881.CrossRefPubMed
14.
15.
Chang L, Ray LB: Whole-istic biology. Science. 2002, 295: 1661-10.1126/science.295.5560.1661.CrossRef
16.
Goldenfeld N, Kadanoff LP: Simple lessons from complexity. Science. 1999, 284: 87-89. 10.1126/science.284.5411.87.CrossRefPubMed
17.
Mocellin S, Rossi CR, Pilati P, Nitti D, Marincola FM: Molecular oncology in the post-genomic era: the challenge of proteomics. Trends Mol Med. 2003, 9: 189-195. 10.1016/S1471-4914(03)00047-9.CrossRefPubMed
18.
No Authors listed: End of the interlude?. Nat Biotechnol. 2004, 22: 1191-10.1038/nbt1004-1191.CrossRef
19.
Stephanopoulos G, Alper H, Moxley J: Exploiting biological complexity for strain improvement through systems biology. Nat Biotechnol. 2004, 22: 1261-1267. 10.1038/nbt1016.CrossRefPubMed
20.
Marincola FM, Wang E, Herlyn M, Seliger B, Ferrone S: Tumors as elusive targets of T-cell-based active immunotherapy. Trends Immunol. 2003, 24: 335-342. 10.1016/S1471-4906(03)00116-9.CrossRefPubMed
21.
Service RF: Complex systems. Exploring the systems of life. Science. 1999, 284: 80-81, 83. 10.1126/science.284.5411.80a.CrossRefPubMed
22.
Butcher EC, Berg EL, Kunkel EJ: Systems biology in drug discovery. Nat Biotechnol. 2004, 22: 1253-1259. 10.1038/nbt1017.CrossRefPubMed
23.
Brenner S: The limits of Reductionism in Biology. Novartis Found Symp 213. Edited by: Bock G, Goode JA. 1998, John Wiley, London, 106-116.
24.
Rose S: What is wrong with reductionist explanations of behaviour?. Novartis Found Symp. 1998, 213: 176-186.PubMed
25.
Sogn JA, Anton-Culver H, Singer DS: Meeting report: NCI think tanks in cancer biology. Cancer Res. 2005, 65: 9117-9120. 10.1158/0008-5472.CAN-05-1817.CrossRefPubMed
26.
Bialek W, Botstein D: Introductory science and mathematics education for 21st-Century biologists. Science. 2004, 303: 788-90. 10.1126/science.1095480.CrossRefPubMed
27.
Martin M: Researchers suggest that universal 'law' governs tumor growth. J Natl Cancer Inst. 2003, 95: 704-705.CrossRefPubMed
28.
Norton L: Conceptual and practical implications of breast tissue geometry: toward a more effective, less toxic therapy. Oncologist. 2005, 10: 370-381. 10.1634/theoncologist.10-6-370.CrossRefPubMed
29.
Michor F, Iwasa Y, Lengauer C, Nowak MA: Dynamics of colorectal cancer. Semin Cancer Biol. 2005, 15: 484-493. 10.1016/j.semcancer.2005.06.005.CrossRefPubMed
30.
Michor F, Hughes TP, Iwasa Y: Dynamics of chronic myeloid leukaemia. Nature. 2005, 435: 1267-1270. 10.1038/nature03669.CrossRefPubMed
31.
Komarova NL: Mathematical modeling of tumorigenesis: mission possible. Curr Opin Oncol. 2005, 17: 39-43. 10.1097/01.cco.0000143681.37692.32.CrossRefPubMed
32.
Nowak MA, Michor F, Komarova NL, Iwasa Y: Evolutionary dynamics of tumor suppressor gene inactivation. Proc Natl Acad Sci USA. 2004, 101: 10635-10638. 10.1073/pnas.0400747101.PubMedCentralCrossRefPubMed
33.
Michor F, Iwasa Y, Nowak MA: Dynamics of cancer progression. Nat Rev Cancer. 2004, 4: 197-205. 10.1038/nrc1295.CrossRefPubMed
34.
Frank SA, Nowak MA: Cell biology: Developmental predisposition to cancer. Nature. 2003, 422: 494-10.1038/422494a.CrossRefPubMed
35.
Grizzi F, Russo C, Portinaro N, Hermonat PL, Chiriva-Internati M: Complexity and cancer. Gastroenterology. 2004, 126: 630-631. 10.1053/j.gastro.2003.12.033.CrossRefPubMed
36.
Abraham R: Complex dynamics. 1991, Aerial Press, Santa Cruz
37.
Abraham R, Shaw C: Dynamics, The geometry of behavior. 1992, Addison-Wesley, Reading MA, Second
38.
Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell. 1990, 61: 759-767. 10.1016/0092-8674(90)90186-I.CrossRefPubMed
39.
Michor F, Iwasa Y, Vogelstein B, Lengauer C, Nowak MA: Can chromosomal instability initiate tumorigenesis?. Semin Cancer Biol. 2005, 15: 43-49. 10.1016/j.semcancer.2004.09.007.CrossRefPubMed
40.
Chan Man Fong CF, De Kee D: Perurbation methods, instability, catastrophe and chaos. 1999, World ScientificCrossRef
41.
Venkitaraman AR: A growing network of cancer-susceptibility genes. N Engl J Med. 2003, 348: 1917-1919. 10.1056/NEJMcibr023150.CrossRefPubMed
42.
Stelling J, Sauer U, Szallasi Z, Doyle FJ, Doyle J: Robustness of cellular functions. Cell. 2004, 118: 675-685. 10.1016/j.cell.2004.09.008.CrossRefPubMed
43.
44.
45.
Kitano H: Cancer as a robust system: implications for anticancer therapy. Nat Rev Cancer. 2004, 4: 227-235. 10.1038/nrc1300.CrossRefPubMed
46.
Lumsden CY, Brandts WA, Trainor LEH: Physical theory in biology. Foundations and explorations. 1997, London: World Scientific
47.
Casti JL: Complexification: explaining a paradoxical world through the science of surprise. 1994, New York: HarperCollins
48.
Grizzi F: The complexity and the microscopy in the anatomical sciences. "Science, Technology and Education of Microscopy: an Overview". 2003, Spain: Formatex
49.
Phillips JD: Entropy analysis of multiple scale causality and qualitative causal shifts in spatial systems. The Professional Geographer. 2005, 57: 83-93.
50.
Schnenider G, Siveke JT, Eckel F, Schmid RM: Pancreatic cancer: basic and clinical aspects. Gastroenterology. 2005, 128: 1606-1625. 10.1053/j.gastro.2005.04.001.CrossRef
51.
Thorgeirsson SS, Grisham JW: Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet. 2002, 31: 339-346. 10.1038/ng0802-339.CrossRefPubMed
Metadata
Title
Cancer: looking for simplicity and finding complexity
Authors
Fabio Grizzi
Maurizio Chiriva-Internati
Publication date
01-12-2006
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2006
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/1475-2867-6-4

Other articles of this Issue 1/2006

Cancer Cell International 1/2006 Go to the issue

Primary research

Action of Lovastatin (Mevinolin) on an in vitro model of angiogenesis and its co-culture with malignant melanoma cell lines

Hypothesis

Mechanisms of genotoxin-induced transcription and hypermutation in p53

Primary research

Direct interaction between the catalytic subunit of Protein Phosphatase 1 and pRb

Primary research

Protease nexin-1 expression is altered in human breast cancer

Primary research

Human LINE-1 retrotransposon induces DNA damage and apoptosis in cancer cells

Primary research

Expression of platelet derived growth factor family members and the potential role of imatinib mesylate for cervical cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits